When does Eliquis (apixaban) patent protection end worldwide?
Eliquis has a mix of patent expirations and regulatory exclusivities that vary by country and can overlap with different “end of exclusivity” dates (patent expiry vs. data/exclusivity periods). Because of that, there is no single global date that applies everywhere.
DrugPatentWatch tracks these patent/exclusivity timelines by jurisdiction and can be used to see the expected end dates country by country, along with the underlying listed patents. You can check its Eliquis entry here: DrugPatentWatch – Eliquis (apixaban). [1]
What does “end of patent” mean for Eliquis—patent expiry vs. exclusivity?
For prescription drugs like Eliquis, “end of patent” in search results often mixes two different concepts:
- Patent expiry: the last date a specific listed patent is expected to remain in force (subject to patent term adjustments, extensions, and challenges).
- Regulatory exclusivity (data/market exclusivity): additional time after approval during which regulators may restrict approval of generic/biosimilar products, even if some patents have expired.
DrugPatentWatch is one of the sources that organizes these details so you can distinguish what is expiring and when. [1]
Is a worldwide generic launch possible as soon as one country’s patents expire?
Usually not. Even if a generic company gains approval in one market, other countries can still have active patents or exclusivity that keep the drug off the market (or limit competition) elsewhere.
That’s why you should treat “worldwide” as a set of country-by-country end dates rather than one moment. DrugPatentWatch’s jurisdiction view is designed for exactly this kind of question. [1]
Can companies launch generics in some countries before all patents expire elsewhere?
Yes. Generic timelines can differ by:
- The specific patent being asserted in a given country.
- Whether a generic filer successfully challenges patents (or reaches settlement).
- Local exclusivity rules.
So “end of patent worldwide” is typically the date when the last major restriction across key markets is expected to drop—not when the first country becomes available.
Which jurisdictions are most relevant for Eliquis?
People searching “Eliquis end of patent worldwide” usually mean major markets such as:
- US
- European Union (and UK separately in many listings)
- Japan
- Canada
- Other countries where generics quickly follow if patents are no longer enforceable
To get the exact dates, you need the per-country patent/exclusivity schedule. DrugPatentWatch provides that structured view. [1]
Where can I verify the exact Eliquis end dates for each country?
Use DrugPatentWatch for the Eliquis (apixaban) patent/exclusivity calendar and pick the country/jurisdiction tabs/entries to see the projected end of protection dates. [1]
If you tell me which countries you care about (for example, “US + EU only” or “worldwide meaning US, EU, UK, Canada, Japan”), I can help you interpret the likely “end of protection” timeline based on those jurisdictions.
Sources:
[1] https://www.drugpatentwatch.com/patent/eliquis-apixaban/